GlaxoSmithKline's share price plunged immediately following the announcement of its second quarter results on Tuesday.» Read More
The White House is coming under pressure from some of its closest allies to name a CEO to run its health insurance marketplace.
Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.
Damien Conover, Equity Analyst at Morningstar talks about the impact of Obamacare on equity markets and highlights stocks that are set to benefit from it.
Merck issued a voluntary recall of lot of its Gardasil vaccines Friday due to the risk that some of the viles may contain glass particles.
Days before a major Obamacare deadline, so-called "direct enrollment" is dramatically below what it might have been because of technical problems.
The only way to get more Obamacare signups is to cut minimum requirements, athenahealth CEO Jonathan Bush tells CNBC.
AIA group chief executive Mark Tucker discusses its deal with Citibank to sell products through Citi's network across Asia.
Why the Obama administration won't provide an extension for the individual mandate, with Democratic strategist Chris Kofinis; Scott Gottlieb, M.D. of American Enterprises Institute; and Paul Howard, senior fellow of Manhattan Institute.
"Sharknado" actor Ian Ziering says actors in unions need to make so much per year to qualify for specific health insurance. He says he signed onto "Sharknado" to keep his insurance.
The Obama administration announced a new series of measures to get as many people as possible are covered Obamacare insurance by Jan. 1.
Get the best of CNBC in your inbox